Skip to main content
Clinical Trials/NCT05592288
NCT05592288CompletedNot Applicable

The Impact of a Mobile Application Designed for Adults at Risk of Developing Diabetes on Following the Mediterranean Diet Plan, Physical Activity and Metabolic Parameters: a Study Protocol for a Randomized Controlled Trial

Akdeniz University1 site in 1 country61 target enrollmentStarted: March 1, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
61
Locations
1
Primary Endpoint
Mediterranean Diet Adherence Screener-MEDAS)

Study Overview

Brief Summary

Aim: The aim of this study is to determine whether a prediabetes mobile application (PREDIABE-TR) designed in Turkish to inform and advise individuals at risk of developing diabetes about healthy eating and physical exercise can make a difference in the participants' eating according to the Mediterranean Diet Plan, or in their physical activity and other diabetes-related metabolic parameters.

Methods: A total of 120 adults at risk of developing diabetes will be assigned into an experimental and a control group by means of Stratified Permuted Block Randomization. The adults in the experimental group will be using the PREDIABE-TR mobile application for a period of 6 months. Over the same period, the control group will use the Turkish Nutrition Guide and the Diabetes Checklists mobile application distributed by the Turkish Ministry of Health. At the end of the six-month period, a review will be made of the diabetes metabolic data, physical activity levels and the Mediterranean Diet eating behaviors. At the same time, an assessment will be made of the control group's use of the mobile application with the help of the Mobile Application Usability Scale. Statistical data will be analyzed using the Statistical Package for the Social Sciences program.

Discussion: The benefits of interventions to promote a healthy lifestyle are evident in terms of preventing a transition from prediabetes to diabetes and maintaining present status. The current novel coronavirus pandemic has clearly shown the advantages of and necessity for remote interventions. In this study, we will attempt to determine whether or not the use of the PREDIABE-TR mobile application can promote a healthy lifestyle and achieve a reduced risk of diabetes.

Impact: This study will serve to provide evidence of the practicality, acceptability and cost effectiveness of various applications (such as mobile apps) that can be an alternative to face-to-face consultation and other medical practices. This alternative can be suggested to policy- and decision-makers. Such applications can also be considered preventive strategies.

Detailed Description

Hypotheses

Our hypotheses were formulated in line with Population-Intervention-Comparison-Outcome-Study; significance was set at 0.05 (Higgins et al., 2019). In addition to standard applications, the intervention group will be using the PREDIABE-TR mobile app. The control group will only use standard applications. In this context, our research hypotheses are the following:

H1a: When compared with the control group, the eating behaviors with regard to adopting the Mediterranean Diet of prediabetic adults using the PREDIABE-TR app will be at a higher level.

H1b: When compared with the control group, the physical activity (MET, number of steps) of prediabetic adults using the PREDIABE-TR app will be at a higher level.

H1c: When compared with the control group, the metabolic parameters (A1C, Impaired Fasting Glucose, Impaired Glucose Tolerance of prediabetic adults using the PREDIABE-TR app will be at lower levels.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Single (Participant)

Masking Description

Single-blind (participant)

Eligibility Criteria

Ages
45 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Individuals to be included will be those who: are prediabetic (Impaired Fasting Glucose =100-125 mg/dl-mmol/L, A1C=5.7%-6.4% or Impaired Glucose Tolerance=140-190 mg/dl-mmol/L),
  • •are active Android/phone operating system cell phone users,
  • •are not pregnant or have any malignancy,
  • •have no hearing or vision impairment,
  • •are at least primary school graduates and fluent in Turkish.

Exclusion Criteria

  • •Individuals who have a diagnosis of diabetes or are using an insulin pump or oral antidiabetic agents,
  • •have vision impairment,
  • •are pregnant,
  • •have any condition that precludes engaging in physical activity,
  • •have psychiatric issues or problems with communicating, will be excluded.

Arms & Interventions

Intervention group

Experimental

The study universe will consist of adults of the ages 45-65 who have received a diagnosis of prediabetes and are registered at the Family Health Center No. 9. PREDIABE-TR mobile app usage (six months).

Intervention: PREDIABE-TR mobile app. (Other)

Control grup

No Intervention

The study universe will consist of adults of the ages 45-65 who have received a diagnosis of prediabetes and are registered at the Family Health Center No. 9. Routine practice (Brochures of the Public Health Directorate, Mobile apps of the Ministry of Health, etc.)

Outcomes

Primary Outcomes

Mediterranean Diet Adherence Screener-MEDAS)

Time Frame: Change 6 months from baseline

The Turkish validity and reliability studies for MEDAS.

Metabolic Measurements

Time Frame: Change 6 months from baseline

The participants' A1C, fasting blood glucose values will be measured. The A1C Measurement represents a 3-month mean value The A1C testing does not require fasting conditions. The blood sample can be taken at any time of day. Over the period of the study, the A1C result the participant has obtained from being tested at any health facility will be taken from the personal health system records.

International Physical Activity Questionnaire (IPAQ)

Time Frame: Change 6 months from baseline

The IPAQ International Physical Activity Questionnaire-Short Form.

Blood Glucose Measurement

Time Frame: Change 6 months from baseline

The researcher will measure the participants' blood glucose with a Roche Accu-Chek® perform nano device. A minimum eight-hour fasting period will be taken as a criterion for fasting blood glucose; a postprandial blood glucose test will be administered 2 hours after a meal.

Secondary Outcomes

  • Continued Intention to Use Scale(6th month)
  • Brand Loyalty Scale(6th month)
  • Height-Weight Measurement and Body Mass Index(Change 6 months from baseline)
  • Mobile Application Usability Scale(6th month)
  • Mobile App Usability and Usage Assessment Scale(6th month)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

İbrahim TOPUZ

Lecturer (PhD student)

Akdeniz University

Study Sites (1)

Loading locations...

Similar Trials